GSEFF - Covivio

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
955,901
955,891
927,410
892,734
885,141
Cost of Revenue
66,986
72,060
77,392
77,311
75,062
Gross Profit
888,915
883,831
850,018
815,423
810,079
Operating Expenses
Research Development
941
585
4,102
1,038
1,077
Selling General and Administrative
119,959
119,591
110,929
103,478
99,385
Total Operating Expenses
80,369
89,078
111,027
98,177
133,834
Operating Income or Loss
808,546
794,753
738,991
717,246
676,245
Interest Expense
179,134
177,159
201,395
198,051
220,630
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
1,182,549
1,259,594
1,463,033
1,190,867
709,929
Income Tax Expense
130,307
116,132
110,452
67,616
42,634
Income from Continuing Operations
1,052,242
1,143,462
1,352,581
1,123,251
667,295
Net Income
639,378
749,574
914,112
782,774
481,472
Net Income available to common shareholders
639,378
749,574
914,112
782,774
481,472
Reported EPS
Basic
-
9.99
12.41
11.57
7.33
Diluted
-
9.22
11.96
10.84
7.29
Weighted average shares outstanding
Basic
-
75,041
73,656
67,634
65,671
Diluted
-
75,547
78,649
72,511
66,041
EBITDA
-
1,631,267
1,682,213
1,414,719
1,011,006